UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy

Journal of clinical oncology, 2013-08, Vol.31 (22), p.2783-2790

2013

Link zum Volltext

Verfügbarkeit prüfen

Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer

Clinical cancer research, 2008-12, Vol.14 (24), p.8019-8026

2008

Link zum Volltext

Verfügbarkeit prüfen

Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers

BMC cancer, 2018-08, Vol.18 (1), p.805-805, Article 805

2018

Link zum Volltext

Verfügbarkeit prüfen

Molecular Profiling of Aromatase Inhibitor―Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance

Clinical cancer research, 2013-05, Vol.19 (10), p.2775-2786

2013

Link zum Volltext

Verfügbarkeit prüfen

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer

Journal of clinical oncology, 2015-07, Vol.33 (20), p.2270-2278

2015

Link zum Volltext

Verfügbarkeit prüfen

Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer

Breast cancer research : BCR, 2021-10, Vol.23 (1), p.95-95, Article 95

2021

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

Journal of clinical oncology, 2010-04, Vol.28 (11), p.1829-1834

2010

Link zum Volltext

Verfügbarkeit prüfen

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population

The lancet oncology, 2013-10, Vol.14 (11), p.1067-1076

2013

Link zum Volltext

Verfügbarkeit prüfen

Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1

Science signaling, 2018-09, Vol.11 (549)

2018

Link zum Volltext

Verfügbarkeit prüfen

Restriction site associated DNA sequencing for tumour mutation burden estimation and mutation signature analysis

Cancer medicine (Malden, MA), 2023-12, Vol.12 (23), p.21545-21560

2023

Link zum Volltext

Verfügbarkeit prüfen

Variable expression quantitative trait loci analysis of breast cancer risk variants

Scientific reports, 2021-03, Vol.11 (1), p.7192-7192, Article 7192

2021

Link zum Volltext

Verfügbarkeit prüfen

ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1

PLoS genetics, 2011-04, Vol.7 (4), p.e1001382-e1001382

2011

Link zum Volltext

Verfügbarkeit prüfen

Structure vs. Function of TRIB1—Myeloid Neoplasms and Beyond

Cancers, 2021-06, Vol.13 (12), p.3060

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of Aromatase Inhibition on Functional Gene Modules in Estrogen Receptor―Positive Breast Cancer and Their Relationship with Antiproliferative Response

Clinical cancer research, 2014-05, Vol.20 (9), p.2485-2494

2014

Link zum Volltext

Verfügbarkeit prüfen

Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women

Journal of clinical oncology, 2010-03, Vol.28 (7), p.1161-1167

2010

Link zum Volltext

Verfügbarkeit prüfen

Increased gene expression variability in BRCA1-associated and basal-like breast tumours

Breast cancer research and treatment, 2021-09, Vol.189 (2), p.363-375

2021

Link zum Volltext

Verfügbarkeit prüfen

Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

Clinical cancer research, 2014-08, Vol.20 (15), p.3962-3973

2014

Link zum Volltext

Verfügbarkeit prüfen

A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse

Clinical cancer research, 2017-06, Vol.23 (12), p.3035-3044

2017

Link zum Volltext

Verfügbarkeit prüfen

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer

Nature genetics, 2000-09, Vol.26 (1), p.16-17

2000

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4518: 4CSeq analysis of a breast cancer susceptibility locus on 6q25.1

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4518-4518

2016

Link zum Volltext

Verfügbarkeit prüfen

Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation

Clinical cancer research, 2011-08, Vol.17 (15), p.4948-4958

2011

Link zum Volltext

Verfügbarkeit prüfen

Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (6), p.2480-2489

2007

Link zum Volltext

Verfügbarkeit prüfen

Association between breast cancer subtypes and response to neoadjuvant anastrozole

Steroids, 2011-07, Vol.76 (8), p.736-740

2011

Link zum Volltext

Verfügbarkeit prüfen

New and translational perspectives of oestrogen deprivation in breast cancer

Molecular and cellular endocrinology, 2011-07, Vol.340 (2), p.137-141

2011

Link zum Volltext

Verfügbarkeit prüfen

Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor―Treated ER-Positive Breast Cancer

Clinical cancer research, 2011-05, Vol.17 (9), p.3005-3012

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(49)
Tagungsberichte
(1)

Sprache

Englisch
(50)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(34)
Humans
(33)
Female
(29)
Oncology
(26)
Tumors
(20)
Breast Cancer
(17)
Biological And Medical Sciences
(16)
Breast Neoplasms - Drug Therapy
(16)
Breast Neoplasms - Genetics
(15)
Breast Neoplasms - Metabolism
(14)
Medical Sciences
(14)
Receptors, Estrogen - Metabolism
(13)
Gene Expression
(12)
Gynecology. Andrology. Obstetrics
(11)
Mammary Gland Diseases
(11)
Anastrozole
(10)
Antineoplastic Agents, Hormonal - Therapeutic Use
(10)
Aromatase Inhibitors - Therapeutic Use
(10)
Cancer
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy

Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer

Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers

Molecular Profiling of Aromatase Inhibitor―Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer

Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer

Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population

Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1

Restriction site associated DNA sequencing for tumour mutation burden estimation and mutation signature analysis

Variable expression quantitative trait loci analysis of breast cancer risk variants

ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1

Structure vs. Function of TRIB1—Myeloid Neoplasms and Beyond

Effect of Aromatase Inhibition on Functional Gene Modules in Estrogen Receptor―Positive Breast Cancer and Their Relationship with Antiproliferative Response

Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women

Increased gene expression variability in BRCA1-associated and basal-like breast tumours

Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer

Abstract 4518: 4CSeq analysis of a breast cancer susceptibility locus on 6q25.1

Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation

Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer

Association between breast cancer subtypes and response to neoadjuvant anastrozole

New and translational perspectives of oestrogen deprivation in breast cancer

Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor―Treated ER-Positive Breast Cancer

Suchergebnisse filtern